ESPR SG&A Expense Growth
Esperion Therapeutics Inc · SG&A Expense Growth
ESPR SG&A Expense Growth
Latest reported1.66%period ending
ESPR FY SG&A Growth (YoY) (0.00% → 1.66%)
Latest values, visible window
High-resolution chart · PNG
ESPR sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 1.6637% | |
| 14.4187% | |
| 30.6568% | |
| -41.032% | |
| -7.3291% | |
| 203.1175% | |
| 98.9727% | |
| 54.8108% | |
| 16.9402% | |
| -9.665% | |
| 85.2957% | |
| 61.9395% | |
| 205.7851% | |
| -6.4089% | |
| 0% | |
| 18.5546% | |
| 70.3289% | |
| 17.1213% | |
| 0% |